These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 26568463)

  • 1. FOXO1 inhibits osteoclastogenesis partially by antagnozing MYC.
    Tan P; Guan H; Xie L; Mi B; Fang Z; Li J; Li F
    Sci Rep; 2015 Nov; 5():16835. PubMed ID: 26568463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sirtuin1 Suppresses Osteoclastogenesis by Deacetylating FoxOs.
    Kim HN; Han L; Iyer S; de Cabo R; Zhao H; O'Brien CA; Manolagas SC; Almeida M
    Mol Endocrinol; 2015 Oct; 29(10):1498-509. PubMed ID: 26287518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-κB and MAPK signaling pathways.
    Li C; Yang Z; Li Z; Ma Y; Zhang L; Zheng C; Qiu W; Wu X; Wang X; Li H; Tang J; Qian M; Li D; Wang P; Luo J; Liu M
    J Bone Miner Res; 2011 Mar; 26(3):644-56. PubMed ID: 20814972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
    Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
    J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-10 inhibits RANKL-mediated expression of NFATc1 in part via suppression of c-Fos and c-Jun in RAW264.7 cells and mouse bone marrow cells.
    Mohamed SG; Sugiyama E; Shinoda K; Taki H; Hounoki H; Abdel-Aziz HO; Maruyama M; Kobayashi M; Ogawa H; Miyahara T
    Bone; 2007 Oct; 41(4):592-602. PubMed ID: 17627913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of osteoclast differentiation and bone resorption by sauchinone.
    Han KY; Yang D; Chang EJ; Lee Y; Huang H; Sung SH; Lee ZH; Kim YC; Kim HH
    Biochem Pharmacol; 2007 Sep; 74(6):911-23. PubMed ID: 17662251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 12-O-tetradecanoylphorbol-13-acetate (TPA) inhibits osteoclastogenesis by suppressing RANKL-induced NF-kappaB activation.
    Wang C; Steer JH; Joyce DA; Yip KH; Zheng MH; Xu J
    J Bone Miner Res; 2003 Dec; 18(12):2159-68. PubMed ID: 14672351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of RANKL-induced osteoclastogenesis by (-)-DHMEQ, a novel NF-kappaB inhibitor, through downregulation of NFATc1.
    Takatsuna H; Asagiri M; Kubota T; Oka K; Osada T; Sugiyama C; Saito H; Aoki K; Ohya K; Takayanagi H; Umezawa K
    J Bone Miner Res; 2005 Apr; 20(4):653-62. PubMed ID: 15765185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Saurolactam inhibits osteoclast differentiation and stimulates apoptosis of mature osteoclasts.
    Kim MH; Ryu SY; Choi JS; Min YK; Kim SH
    J Cell Physiol; 2009 Dec; 221(3):618-28. PubMed ID: 19653230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FoxO1 knockdown inhibits RANKL-induced osteoclastogenesis by blocking NLRP3 inflammasome activation.
    Wang Z; Luo W; Zhang G; Li H; Zhou F; Wang D; Feng X; Xiong Y; Wu Y
    Oral Dis; 2024 Jul; 30(5):3272-3285. PubMed ID: 37927112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decitabine represses osteoclastogenesis through inhibition of RANK and NF-κB.
    Guan H; Mi B; Li Y; Wu W; Tan P; Fang Z; Li J; Zhang Y; Li F
    Cell Signal; 2015 May; 27(5):969-77. PubMed ID: 25683916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HDAC2 regulates FoxO1 during RANKL-induced osteoclastogenesis.
    Dou C; Li N; Ding N; Liu C; Yang X; Kang F; Cao Z; Quan H; Hou T; Xu J; Dong S
    Am J Physiol Cell Physiol; 2016 May; 310(10):C780-7. PubMed ID: 26962001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rhinacanthin C Inhibits Osteoclast Differentiation and Bone Resorption: Roles of TRAF6/TAK1/MAPKs/NF-κB/NFATc1 Signaling.
    Tomomura M; Suzuki R; Shirataki Y; Sakagami H; Tamura N; Tomomura A
    PLoS One; 2015; 10(6):e0130174. PubMed ID: 26083531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-506 upregulation contributes to sirtuin 1 inhibition of osteoclastogenesis in bone marrow stromal cells induced by TNF-α treatment.
    Yan S; Miao L; Lu Y; Wang L
    Cell Biochem Funct; 2019 Dec; 37(8):598-607. PubMed ID: 31515847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ormeloxifene inhibits osteoclast differentiation in parallel to downregulating RANKL-induced ROS generation and suppressing the activation of ERK and JNK in murine RAW264.7 cells.
    Kharkwal G; Chandra V; Fatima I; Dwivedi A
    J Mol Endocrinol; 2012 Jun; 48(3):261-70. PubMed ID: 22493142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-142-5p promotes the osteoclast differentiation of bone marrow-derived macrophages via PTEN/PI3K/AKT/FoxO1 pathway.
    Lou Z; Peng Z; Wang B; Li X; Li X; Zhang X
    J Bone Miner Metab; 2019 Sep; 37(5):815-824. PubMed ID: 30900017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of receptor activator of nuclear factor-κB ligand- or lipopolysaccharide-induced osteoclast formation by conophylline through downregulation of CREB.
    Koide N; Kondo Y; Odkhuu E; Ulziisaikhan J; Ukaji T; Yokochi T; Umezawa K
    Immunol Lett; 2014 Sep; 161(1):31-7. PubMed ID: 24792671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effects of Stewartia koreana on osteoclast differentiation and bone resorption.
    Park CK; Kim HJ; Kwak HB; Lee TH; Bang MH; Kim CM; Lee Y; Chung DK; Baek NI; Kim J; Lee ZH; Kim HH
    Int Immunopharmacol; 2007 Dec; 7(12):1507-16. PubMed ID: 17920527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coenzyme q10 regulates osteoclast and osteoblast differentiation.
    Moon HJ; Ko WK; Jung MS; Kim JH; Lee WJ; Park KS; Heo JK; Bang JB; Kwon IK
    J Food Sci; 2013 May; 78(5):H785-891. PubMed ID: 23582186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epoxyeicosanoids suppress osteoclastogenesis and prevent ovariectomy-induced bone loss.
    Guan H; Zhao L; Cao H; Chen A; Xiao J
    FASEB J; 2015 Mar; 29(3):1092-101. PubMed ID: 25466887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.